NCT05520112

Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells

Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells Capable of Differentiation in the Endometrial-decidual Direction

• Status: Unknown
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus · Other Government
• Sex: Female
• Age: 18 Years – 49 Years
• Healthy volunteers: Not accepted

Summary

Treatment of Recurrent pregnancy loss using mesenchymal stem cells capable of differentiation in the endometrial-decidual direction.

Detailed description

Treatment of Recurrent pregnancy (characterized by the presense of thin endometrium) loss using mesenchymal stem cells capable of differentiation in the endometrial-decidual direction.

Conditions

• Recurrent Pregnancy Loss

Interventions

Type	Name	Description
BIOLOGICAL	Mesenchymal stem cells capable of differentiation in the endometrial-decidual direction	Mesenchymal stem cells capable of differentiation in the endometrial-decidual direction
OTHER	Standard treatment according to the clinical protocols	Standard treatment of Recurrent Pregnancy Loss according to the clinical protocols

Timeline

• Start date: 2022-11-01
• Primary completion: 2023-12-31
• Completion: 2023-12-31
• First posted: 2022-08-29
• Last updated: 2022-08-29

Locations

1 site across 1 country: Belarus